Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Gsk1325756
2. N-(4-chloro-2-hydroxy-3-(3-piperidinylsulfonyl)phenyl)-n'-(3-fluoro-2-methylphenyl)urea
1. 954126-98-8
2. Gsk1325756
3. Gsk-1325756b
4. Gsk1325756b
5. R318pgh5vp
6. Danirixin (gsk1325756)
7. (s)-1-(4-chloro-2-hydroxy-3-(piperidin-3-ylsulfonyl)phenyl)-3-(3-fluoro-2-methylphenyl)urea
8. 1-(4-chloro-2-hydroxy-3-(((3s)-piperidine-3-sulfonyl)phenyl)-3-(3-fluoro-2-methylphenyl)urea
9. Gsk-1325756
10. 1-[4-chloro-2-hydroxy-3-[(3s)-piperidin-3-yl]sulfonylphenyl]-3-(3-fluoro-2-methylphenyl)urea
11. Danirixin [usan:inn]
12. Unii-r318pgh5vp
13. Gsk 1325756
14. Danirixin [inn]
15. Danirixin (usan/inn)
16. Danirixin [usan]
17. Danirixin [who-dd]
18. Gtpl8500
19. Schembl1198688
20. Chembl3039531
21. Ex-a1178
22. Mfcd27987922
23. Zinc95627831
24. Cs-5465
25. Db11922
26. Ac-36168
27. Hy-19768
28. S6620
29. D10387
30. Q27076980
31. N-(4-chloro-2-hydroxy-3-(3-piperidinylsulfonyl)phenyl)-n'-(3-fluoro-2-methylphenyl)urea
32. Urea, N-[4-chloro-2-hydroxy-3-[(3s)-3-piperidinylsulfonyl]phenyl]-n'-(3-fluoro-2-methylphenyl)-
| Molecular Weight | 441.9 g/mol |
|---|---|
| Molecular Formula | C19H21ClFN3O4S |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 441.0925332 g/mol |
| Monoisotopic Mass | 441.0925332 g/mol |
| Topological Polar Surface Area | 116 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 677 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
98
PharmaCompass offers a list of Danirixin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Danirixin manufacturer or Danirixin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Danirixin manufacturer or Danirixin supplier.
PharmaCompass also assists you with knowing the Danirixin API Price utilized in the formulation of products. Danirixin API Price is not always fixed or binding as the Danirixin Price is obtained through a variety of data sources. The Danirixin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Danirixin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Danirixin, including repackagers and relabelers. The FDA regulates Danirixin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Danirixin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Danirixin supplier is an individual or a company that provides Danirixin active pharmaceutical ingredient (API) or Danirixin finished formulations upon request. The Danirixin suppliers may include Danirixin API manufacturers, exporters, distributors and traders.
Danirixin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Danirixin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Danirixin GMP manufacturer or Danirixin GMP API supplier for your needs.
A Danirixin CoA (Certificate of Analysis) is a formal document that attests to Danirixin's compliance with Danirixin specifications and serves as a tool for batch-level quality control.
Danirixin CoA mostly includes findings from lab analyses of a specific batch. For each Danirixin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Danirixin may be tested according to a variety of international standards, such as European Pharmacopoeia (Danirixin EP), Danirixin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Danirixin USP).
